2019年EULAR/ACR系统性红斑狼疮分类标准
该国际倡议分四阶段制定新分类标准:以ANA阳性为强制准入条件,继以7个临床域和3个免疫域加权评分(2-10分),累计≥10分可分类。验证队列中敏感性96.1%、特异性93.4%,优于ACR 1997和SLICC 2012标准。
要点
- ANA阳性至少一次为强制准入条件,不满足则不分类。
- 7个临床域和3个免疫域加权评分,累计≥10分可分类。
- 验证队列敏感性96.1%、特异性93.4%,优于既往标准。
核心结论
- 新分类标准采用ANA准入、层级聚类加权评分,具有优异敏感性和特异性。
研究设计与样本
- 国际多学科倡议分四阶段制定:系统评价与Meta回归、德尔菲法、多准则决策分析、推导与验证队列。
- 在1001例受试者中推导权重与阈值,在1270例受试者中验证并与既往标准比较。
主要发现
- 验证队列中新标准敏感性96.1%、特异性93.4%。
- ACR 1997标准敏感性82.8%、特异性93.4%。
- SLICC 2012标准敏感性96.7%、特异性83.7%。
关键数值与推荐
- ANA阳性至少一次为强制准入条件。
- 7个临床域(全身、血液、神经精神、黏膜皮肤、浆膜、肌肉骨骼、肾脏)和3个免疫域(抗磷脂抗体、补体蛋白、SLE特异性抗体)加权2-10分。
- 累计≥10分可分类为SLE。
临床怎么用
- 临床可先确认ANA阳性,再按域加权评分,累计≥10分可分类。
- 该标准为分类标准,用于研究入组,不直接作为临床诊断依据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). METHODS: This international initiative had four phases. (1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort and a patient survey. (2) Criteria reduction by Delphi and nominal group technique exercises. (3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. (4) Refinement of weights and threshold scores in a new derivation cohort of 1001 subjects and validation compared with previous criteria in a new validation cohort of 1270 subjects. RESULTS: The 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in seven clinical (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and three immunological (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria. CONCLUSION: These new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered and weighted criteria reflect current thinking about SLE and provide an improved foundation for SLE research.
引用
- Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019. PMID: 31383717. doi:10.1136/annrheumdis-2018-214819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。